Gary Reys, the Seattle man facing civil charges from the U.S. Securities and Exchange Commission for the CellCyte Genetics Corp. pump-and-dump, has won a motion to dismiss the complaint. He successfully argued that one paragraph of the complaint was too vague in describing how he approved text used in spam e-mails, blast faxes and newsletters touting CellCyte. He said that the paragraph did not state what fraudulent statements he made, or how they were fraudulent.